Pemetrexed/Oxaliplatin for First-Line Treatment of Patients with Advanced Colorectal Cancer: A Phase II Trial of the National Surgical Adjuvant Breast and Bowel Project Foundation Research Program
Authors:
- Samuel A. JacobsSJSamuel A. Jacobs
- H. Samuel WieandHWH. Samuel Wieand
- Roy E. SmithRSRoy E. Smith
- William J. JohnWJWilliam J. John
- Linda H. ColangeloLCLinda H. Colangelo
- Victor G. VogelVVVictor G. Vogel
- J. Philip KueblerJKJ. Philip Kuebler
- Terrence P. CesconTCTerrence P. Cescon
- Barbara J. MillerBMBarbara J. Miller
- Charles E. GeyerCGCharles E. Geyer
- Norman WolmarkNWNorman Wolmark
- 1 September 2005
- journal article
- research article
- Published by Elsevier in Clinical Colorectal Cancer
- Vol. 5 (3) , 181-187
Abstract
No abstract availableKeywords
This publication has 19 references indexed in Scilit:
- Modulation of Fluorouracil by Leucovorin in Patients With Advanced Colorectal Cancer: An Updated Meta-AnalysisJournal of Clinical Oncology, 2004
- Phase I and pharmacokinetic study of the multitargeted antifolate pemetrexed in combination with oxaliplatin in patients with advanced solid tumorsAnnals of Oncology, 2004
- XELOX (Capecitabine Plus Oxaliplatin): Active First-Line Therapy for Patients With Metastatic Colorectal CancerJournal of Clinical Oncology, 2004
- FOLFIRI Followed by FOLFOX6 or the Reverse Sequence in Advanced Colorectal Cancer: A Randomized GERCOR StudyJournal of Clinical Oncology, 2004
- A Randomized Controlled Trial of Fluorouracil Plus Leucovorin, Irinotecan, and Oxaliplatin Combinations in Patients With Previously Untreated Metastatic Colorectal CancerJournal of Clinical Oncology, 2004
- Phase III Study of Pemetrexed in Combination With Cisplatin Versus Cisplatin Alone in Patients With Malignant Pleural MesotheliomaJournal of Clinical Oncology, 2003
- Irinotecan plus Fluorouracil and Leucovorin for Metastatic Colorectal CancerNew England Journal of Medicine, 2000
- Activity of multitargeted antifolate (pemetrexed disodium, LY231514) in patients with advanced colorectal carcinomaCancer, 2000
- New Guidelines to Evaluate the Response to Treatment in Solid TumorsJNCI: Journal of the National Cancer Institute, 2000
- Nonparametric Estimation from Incomplete ObservationsJournal of the American Statistical Association, 1958